423 related articles for article (PubMed ID: 3164254)
21. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
[TBL] [Abstract][Full Text] [Related]
23. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
24. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
25. The induction of Friend erythroleukaemia differentiation is markedly affected by expression of a transfected c-myb cDNA.
McMahon J; Howe KM; Watson RJ
Oncogene; 1988 Dec; 3(6):717-20. PubMed ID: 2577875
[TBL] [Abstract][Full Text] [Related]
26. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
27. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
Tsiftsoglou AS; Wong W
Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
[TBL] [Abstract][Full Text] [Related]
28. Oncogene expression in Rauscher murine leukemia virus induced erythroid, myeloid and lymphoid cell lines.
de Both NJ; van der Feltz MJ; Mooren A; Vermaas D; Klaassen P; Rhijnsburger EH; Kranendonk-Odijk ME
Leuk Res; 1989; 13(1):53-64. PubMed ID: 2915575
[TBL] [Abstract][Full Text] [Related]
29. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines.
Tsuda H; Aso N; Sawada T; Hata H; Kawakita M; Mori KJ; Takatsuki K
Int J Cell Cloning; 1991 Mar; 9(2):123-33. PubMed ID: 2037810
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between expression of c-myc and P53 genes and terminal differentiation during induced differentiation in Friend erythroleukemia cells].
Liu HT; Zhang HQ; Xue SB; Du CY; You JS; Song PG; Wang XL; Chen RX
Shi Yan Sheng Wu Xue Bao; 1988 Sep; 21(3):311-9. PubMed ID: 3066081
[No Abstract] [Full Text] [Related]
31. Proto-oncogene expression in chicken leukemic cells induced by avian myeloblastosis virus.
Kim WK; Baluda MA
Oncogene Res; 1988 Sep; 3(2):147-54. PubMed ID: 3226723
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of c-onc genes in choriocarcinoma cells].
Fujino T
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):798-807. PubMed ID: 3692432
[TBL] [Abstract][Full Text] [Related]
33. Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission.
Preisler HD; Kinniburgh AJ; Wei-Dong G; Khan S
Cancer Res; 1987 Feb; 47(3):874-80. PubMed ID: 2433029
[TBL] [Abstract][Full Text] [Related]
34. Erythroproliferation in vitro can be induced by abl, fes, src, ras, bas, raf, raf/myc, erb B and cbl oncogenes but not by myc, myb and fos.
Klinken SP
Oncogene Res; 1988 Sep; 3(2):187-92. PubMed ID: 3226726
[TBL] [Abstract][Full Text] [Related]
35. N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.
Sejersen T; Björklund H; Sümegi J; Ringertz NR
J Cell Physiol; 1986 May; 127(2):274-80. PubMed ID: 3700483
[TBL] [Abstract][Full Text] [Related]
36. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
[TBL] [Abstract][Full Text] [Related]
37. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
38. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
Yen A; Samuel V; Forbes M
J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
[TBL] [Abstract][Full Text] [Related]
39. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
